Ensign Peak Advisors, Inc

Holdings History for IDEAYA Biosciences, Inc. - Common Stock, par value $0.0001 per share (IDYA)

Symbol: IDYA on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.06%	+0.01%	$33,846,208	979,063	+225,899	+30%	$34.57	Q4 2025
30 Sep 2025	0.03%	+0%	$20,493,592	753,164	+11,331	+1.5%	$27.21	Q3 2025
30 Jun 2025	0.03%	+0.01%	$15,593,330	741,833	+414,189	+126%	$21.02	Q2 2025
31 Mar 2025	0.01%	-0.01%	$5,366,809	327,644	-236,573		$16.38	Q1 2025
31 Dec 2024	0.03%	-0%	$14,500,377	564,217	-47,597	-7.8%	$25.70	Q4 2024
30 Sep 2024	0.03%	+0.01%	$19,382,268	611,814	+128,100	+26%	$31.68	Q3 2024
30 Jun 2024	0.03%	-0%	$16,983,199	483,714	-4,656	-0.95%	$35.11	Q2 2024
31 Mar 2024	0.04%	-0%	$21,429,675	488,370	-1,669	-0.34%	$43.88	Q1 2024
31 Dec 2023	0.03%	+0.01%	$17,435,588	490,039	+126,255	+35%	$35.58	Q4 2023
30 Sep 2023	0.02%	+0.01%	$9,814,892	363,784	+130,350	+56%	$26.98	Q3 2023
30 Jun 2023	0.01%	+0.01%	$5,485,699	233,434	+141,023	+153%	$23.50	Q2 2023
31 Mar 2023	0%	0%	$1,268,803	92,411	0		$13.73	Q1 2023
31 Dec 2022	0%	-0%	$1,679,108	92,411	-7,760	-7.7%	$18.17	Q4 2022
30 Sep 2022	0%	+0%	$1,495,000	100,171	+5,390	+5.7%	$14.92	Q3 2022
30 Jun 2022	0%	0%	$1,308,000	94,781	0		$13.80	Q2 2022
31 Mar 2022	0%	+0%	$1,061,000	94,781	+2,370	+2.6%	$11.19	Q1 2022
31 Dec 2021	0%	+0%	$2,185,000	92,411	+55,496	+150%	$23.64	Q4 2021
30 Sep 2021	0%	0%	$941,000	36,915	0		$25.49	Q3 2021
30 Jun 2021	0%	0%	$775,000	36,915	0		$20.99	Q2 2021
31 Mar 2021	0%	0%	$868,000	36,915	0		$23.51	Q1 2021
31 Dec 2020	0%	0%	$517,000	36,915	0		$14.01	Q4 2020
30 Sep 2020	0%	+0%	$464,000	36,915	+36,915	NEW	$12.57	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.